pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 7·1 min read
save

STAT Health Tech newsletter highlights OpenAI health policy ideas and Dexcom CGM updates

May 7, 2026·read at STAT ↗Neutral

The latest STAT Health Tech newsletter, edited by Mario Aguilar, offers a roundup of recent technology developments in health care.

OpenAI proposes a set of health policy recommendations aimed at guiding the responsible use of artificial intelligence in clinical settings.

Dexcom provides updates on its continuous glucose monitoring (CGM) technology, outlining new features and potential market impact.

The edition also notes industry concerns about whole-body scanning technologies and includes information on how readers can subscribe for full access.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and more”

read at STAT ↗
444 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 8h agoHospitals’ next lucrative bet — longevity clinicsSTAT
  • 9h agoSTAT+: Up and down the ladder: The latest comings and goingsSTAT
  • 10h agoSTAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and moreSTAT
  • 10h agoSTAT+: RevMed’s pancreatic cancer drug nears European approvalSTAT
  • 11h agoWhat to read before you go see that new documentary on Elizabeth HolmesSTAT